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Abstract
Background: The immunologic findings that most consistently correlate with resistance in human schistosomiasis are high
levels of IgE and low levels of IgG4. We have genotyped gene and promoter polymorphisms of cytokines associated with
regulation of these isotypes in a cohort of men occupationally exposed to Schistosoma mansoni in western Kenya and
evaluated their patterns with respect to resistance and susceptibility to reinfection after treatment and cure with
praziquantel (PZQ).
Methodology/Principal Findings: In this cohort, polymorphisms in IL-4 (2590T high IgE), IL-13 (21055T high producer) and
IFN-c (+874A high producer) demonstrated several correlations with resistance to reinfection. Resistance to reinfection was
significantly correlated with the heterozygous IL-4 2590 genotype C/T (OR 3.5, [CI 1.2, 10.2]) compared to T/T. Among men
with a homozygous IL-13 genotype CC/TT, having a T allele at the IFN-c +874 position increased the odds of resistance
relative to individuals with the IFN-c +874 A/A genotype (OR=17.5 [CI 3.0, 101.5]). Among men with homozygous A/A IFN-c
genotype, the heterozygous IL-13 genotype C/T was associated with resistance relative to the homozygous C/C or T/T
genotypes (OR=22.5 [CI 3.5, 144.4]). No increases in odds of resistance were found in relation to the IL-13 genotype among
those with a T allele in the IFN-c gene or in relation to the IFN-c genotype among those with a heterozygous IL-13
genotype. Calculation of the attributable proportion of resistance showed a significant synergistic interaction between IL-13
21055 C/T and IL-4 2590 C/T.
Conclusions: The identified polymorphisms do not by themselves confer resistance or susceptibility, but we propose that
these genotypes allow the resistant phenotype to be developed and expressed upon suitable immune exposure. Based on
the literature, these polymorphisms contribute to the regulation of their respective cytokines, likely leading to downstream
differences in the production and interrelationships of critical defense mechanisms.
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Introduction
There have been many studies of resistance to schistosome
infections in humans following treatment and reinfection. Such
studies involve documentation of cases of schistosomiasis, their
treatment and cure, and examinations at a later date to see if
reinfections occurred [1,2,3,4]. Of all the immunologic findings
associated with these investigations, the most consistent observation is
that resistance (usually defined as lower levels of infection) correlates
with high IgE and low IgG4 antibodies against schistosome antigens
[5,6,7,8,9,10,11,12,13,14,15,16,17,18]. Other studies have reported
that production of IFN-c and IL-5 to schistosome antigens are also
correlated with resistance [19,20,21,22].
A genetic region (SM1) has been identified that shows a strong
positive correlation to the level of infection in humans [23]. SM1
maps to chromosome 5 in the 5q31–q33 region that contains
several genes associated with immune responses [24,25]. These
genes code for proteins that are associated with the regulation of
Th2-type responses such as IL-3, IL-4, IL-5, IL-9, and IL-13 and
IgE. Polymorphisms in these cytokines that lead to an increase or
decrease in cytokine levels could influence the antibody isotypes
and cellular interactions that in turn may contribute to resistance
or susceptibility of individuals to reinfection with schistosomiasis.
There have been contradictory reports on the effect the IL-4
2590 C/T (rs 2243250) polymorphism has on IgE levels in
different settings. One group found that infants with a IL-4 2590
C allele had a higher risk of elevated IgE in their cord blood [26].
However, it was also reported that total IgE levels were
significantly elevated in children with severe malaria carrying
the 2590T allele [27]. It is well known that IL-4 plays an
www.plosntds.org 1 February 2009 | Volume 3 | Issue 2 | e375important role in IgE class switching [28] and reports that the
2590 C/T polymorphism are associated with differing amounts
of IgE made it a candidate for this study.
Kouriba, et al. reported that IL-13 21055C (rs 1800925) and
2591A (rs 2069743) were associated with the upper 10% infection
levels in individuals infected with S. haematobium (susceptibility)
[29]. Van der Pouw Kraan et al. described an NF-AT binding site
at IL-13 -1055 that showed increased binding of nuclear proteins
with the T allele [30]. Furthermore, it was reported that
transcription of the IL-13 -1055T allele was enhanced in Th2
polarized CD4+ cells, but not in nonpolarized (i.e., Th0) CD4+ T
cells [31]. Thus, the IL-13-1055 polymorphism, and possibly
2591, could be important in resistance to S. mansoni. The R130Q
SNP (G/A) (rs 20541) in IL-13 causes a replacement of arginine
with glutamine in a helix D, a region involved in IL-13
interactions with IL-13 receptors [32]. The glutamine variant
has been associated with increased levels of total serum IgE [33]
and atopy [34]. It has also been shown that soluble IL-13Ra2 (an
IL-13 decoy receptor) neutralizes the arginine variant more
effectively than the glutamine variant [32]. This may suggest a
possible feedback mechanism that could account for increased
total serum IgE in the glutamine variant.
While most studies have found that Th2 responses are
associated with resistance to reinfection with schistosomiasis, other
studies found that IFN-c production correlates to resistance
[19,20,21]. Pravica et al. showed that the +874T (rs 2430561)
allele corresponds with high production of IFN-c and that the A/
T site coincides with a putative NF-kappa B binding site [35].
These studies prompted us to include the IFN-c +874 polymor-
phism in our study.
IL-10 has been shown to influence IgE and IgG4 production
[36]. Differential production of IL-10 has been shown to be
associated with different allelic variants of the IL-10 promoter
(21082 A/G [rs 1800896], 2819 T/C [rs 1800871], and 2592
A/C [rs 1800872]). The different haplotypes that have been
associated with production of IL-10 are as follows: ‘‘high’’ IL-10
producer haplotype (GCC/GCC), ‘‘intermediate’’ producer
haplotypes (GCC/ACC, GCC/ATA), and ‘‘low’’ producer
haplotypes (ATA/ATA, ACC/ATA, ACC/ACC) [37]. Indeed,
the ATA/ATA haplotype has been associated with increased
eosinophil counts and circulating IgE in adult asthma when
compared to the other possible haplotypes [38]. However, the
group that first described these polymorphisms conclude that high
IL-10 production was dependant on having a G in the 21082
position independent of the 2819 and 2592 polymorphisms [39].
Furthermore, Ruess et al. has shown that 21082A binds PU.1,
which can inhibit gene transcription.
Based on these and other studies, we examined possible
relationships between single nucleotide polymorphisms in the IL-
4( 2590 C/T), IL-13[(21055 C/T), (2591A/G), (R130Q G/A)],
IL-10 (21082 A/G; 2819 C/T; 2592 C/A), and IFN-c (+874A/
T) genes or promoters in relation to resistance and susceptibility to
schistosomiasis of a cohort of occupationally exposed adult men
many of whom we have studied longitudinally for as long as 12
years [40,41].
Materials and Methods
Study participants
The field site for this study was the western Kenyan city of
Kisumu on the shores of Lake Victoria. S. mansoni-infected
Biomphalaria sudanica snails have been identified (data unpublished)
in the area around the exposure site. The study participants were
all car washers occupationally exposed to S. mansoni as they stood
in Lake Victoria, using its waters to wash cars driven into the
shallow areas of the lake. This study was performed on a total of
87 car washers (all adult men). However, it was not possible to use
all data from every individual in every analysis; some epidemio-
logic data regarding infections, cures or reinfections were
insufficient or incomplete.
This investigation was approved by the Institutional Review
Boards of the University of Georgia and the Centers for Diseases
Control and Prevention, the Scientific Steering Committee of the
Kenya Medical Research Institute (KEMRI), and the National Ethics
Review Committee of Kenya. After obtaining written informed
consent and enrolling the participants, we examined their stools for S.
mansoni eggs and for other helminth ova by the modified Kato-Katz
method (Vestergaard-Frandsen, Denmark). In most instances, this
involved 2 slides per stool specimen from 3 stool specimens over a one
week period. The participants who were positive for S. mansoni were
treated with 40 mg/kg praziquantel (PZQ); men positive for other
soil-transmittedhelmintheggsweretreated with400 mg albendazole.
Individuals’ stools were checked 6 weeks after treatment and the men
were retreated if still egg positive. Upon becoming egg negative, they
were then followed by stool examination every 4 weeks to determine
their time to reinfection as a means of determining their relative
resistance to reinfection (see below).
DNA preparation
White blood cell-containing buffy coats were separated using
the Ficoll-hypaque technique from blood obtained for immuno-
logical assays. The buffy coats were stored at 220uC and DNA
was isolated at KEMRI/CGHR laboratories using the WizardH
Genomic DNA Purification Kit from Promega. DNA from 300 ml
of buffy coat for each car washer was isolated per the
manufacturer’s instructions. Dried DNA pellets were then
transported to Athens, Georgia, USA for genotyping.
PCR reactions
PCR reactions of IL-13 and IL-4 SNPs were performed on a
PTC-200 DNA Engine from MJ Research. PCR of the IL-13
Author Summary
Approximately 200 million people have schistosomiasis in
parts of Africa, South America, the Middle East, the
Caribbean and Asia. Several studies of multiple treatments
and reinfections indicate that some people develop
resistance to reinfection. Of all the immunologic findings
associated with such studies, the most consistent observa-
tion is that resistance (usually defined as lower levels of
infection upon reinfection) correlates with high IgE and low
IgG4 antibodies against schistosome antigens. Our studies
test whether single nucleotide polymorphisms residing in
the gene or promoter regions of cytokines pivotal in
controlling production of these antibody isotypes are
different amongst those that develop resistance to reinfec-
tion as opposed to those that do not. Through genotyping
of these polymorphisms in a cohort of occupationally
exposed car washers, we found that men with certain
genotypic patterns of polymorphisms in IL-4, IFN-c, and IL-
13 were significantly more likely to be resistant to
reinfection than those with different patterns. These data
provide initial insights into the potential genetic foundation
of propensities of people to develop resistance to
reinfection by schistosomes, and offer a basis for further
molecular studies of how these polymorphisms might work
at the transcriptional and gene product level in cells
stimulated by schistosome antigens.
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DNA, 5 mlo f1 6 Qiagen PCR buffer, 0.5 mM of each dNTP,
0.4 mM of each primer, 1 mM MgCl2, and 2.5 U of Taq
polymerase (Qiagen). The following sequences were used: forward
primer, 59-ATGCCTTGTGAGGAGGGTCAC; reverse primer,
59-CCAGTCTCTGCAGGATCAACC [42]. Initial denaturation
was performed at 95uC for 3 min followed by 30 cycles of PCR
with the following conditions: 95uC for 30 sec, 62uC for 30 sec for
annealing, 72uC for 1 min, and a final 72uC for 3 min. PCR of the
IL-13 2591 A/G was conducted in a 50 ml reaction containing
100 ng DNA, 5 mlo f1 6 Qiagen PCR buffer, 0.5 mM of each
dNTP, 0.4 mM of each primer, 3 mM MgCl2, and 2.5 U of Taq
polymerase (Qiagen). Initial denaturation was performed at 94uC
for 5 min followed by 34 cycles of PCR with the following
conditions: 94uC for 1 min, 61uC for 45 sec for annealing, 72uC
for 45 sec, and a final 72uC for 3 min. The following sequences
were used: forward primer, 59-CCAGCCTGGCCCAGTTAA-
GAGTTT; reverse primer, 59-CTAATTCCTCCTTGGCCC-
CACT [29]. PCR of the IL-13 +130 G/A was conducted in a
50 ml reaction containing 100 ng DNA, 5 mlo f1 6Qiagen PCR
buffer, 0.5 mM of each dNTP, 0.4 mM of each primer, 1 mM
MgCl2, and 2.5 U of Taq polymerase (Qiagen). Initial denatur-
ation was performed at 94uC for 5 min followed by 34 cycles of
PCR with the following conditions: 94uC for 1 min, 60uC for
45 sec for annealing, 72uC for 45 sec, and a final 72uC for 3 min.
The following sequences were used: forward primer, 59-
TGGCGTTCTACTCACGTGCT; reverse primer, 59-CAGCA-
CAGGCTGAGGTCTAA [43]. PCR of the IL-4 2590 C/T was
conducted in a 50 ml reaction containing 100 ng DNA, 5 mlo f1 6
Qiagen PCR buffer, 0.5 mM of each dNTP, 0.4 mM of each
primer, 1 mM MgCl2, and 2.5 U of Taq polymerase (Qiagen).
Initial denaturation was performed at 95uC for 5 min followed by
31 cycles of PCR with the following conditions: 94uC for 30 sec,
59uC for 30 sec for annealing, 72uC for 30 sec, and a final 72uC
for 3 min. The following sequences were used: forward primer, 59-
ACTAGGCCTCACCTGATACG; reverse primer, 59-
GTTGTAATGCAGTCCTCCTG [44].
Genotyping
Purified PCR products of the IL-13 21055 C/T and IL-4
2590 C/T PCR reactions were sequenced using the reverse
primers for each and the forward primers for IL-13 +130 G/A and
IL-13 2591 A/G on an ABI 3100 by the Office of Research
Services at The University of Georgia. The polymorphisms IL-10
21082, IL-10 2819, IL-10 2592, and IFN-c +874A/T were
genotyped using sequence-specific primers (SSP) in The Cytokine
Genotyping Tray (One Lambda; Canoga Park, CA) as per the
manufacturer’s instructions.
Resistance
Resistance is based on the number of cars washed from the time
of a successful cure until the next reinfection. For all participants,
the number of cars washed between each cure and reinfection over
the entire duration of the study was plotted and the patterns
examined. Two dominant patterns emerged, with participants
either becoming reinfected after washing approximately the same
number of cars between each cure and reinfection or participants
washing progressively more cars between successive cure-reinfec-
tion intervals. The majority of those in the former group (classified
as ‘‘susceptible’’) became reinfected after washing approximately
250–300 cars regardless of how many times they were cured and
reinfected. Those men who demonstrated a pattern of increasing
numbers of cars washed before subsequent reinfections were
classified as ‘‘developing resistance’’ during this study. All men
classified as ‘‘developing resistance’’ eventually washed at least 450
cars before reinfection after being followed for at least 3 cure-to-
reinfection intervals. Some men (classified as ‘‘initially resistant’’)
washed at least 450 cars after the initial cure and continued to
wash a high number of cars before each reinfection. For analysis
purposes, men classified as ‘‘developing resistance’’ and ‘‘initially
resistant’’ were grouped into a single ‘‘resistant’’ category because
frequencies of genotypes did not differ significantly between these
two groups, and conceptually these groups indicate either the
existence of established resistance or the ability to develop
resistance. Resistance data are based on a mean follow-up time
of 7.5 years (range 0.9–12.2 yrs) months and a mean of 7 cure-to-
reinfection intervals. Men were excluded from the analysis when
the number of cars washed between each cure and reinfection
could not be classified into a particular pattern (3 men) or they had
insufficient follow up data (16 men) for accurate classification.
Statistical methods
Odds ratios (ORs) and corresponding 95% confidence intervals
(CIs) for the association between resistance and each genotype
were calculated using univariate analyses and in a multivariate
logistic regression model containing variables for all three
genotypes. To test for interactions between genotypes, categorical
interaction terms with 4 levels were created for each possible two-
way interaction between the 3 dichotomized genotypes. The
combination of alleles with the lowest frequency of resistant
subjects was considered the referent category in each set of terms.
Separate logistic regression models were run for each series of two-
way interaction terms. Inclusion of a term for the third genotype
did not appreciably change the results of any of the interaction
models and was thus ultimately not included in any of the reported
analyses of interactions.
Interactions were assessed on both a multiplicative and additive
scale. Multiplicative interactions are indicative of the need to
estimate stratum-specific effects for the combination of two
genotypes, rather than a single estimate for each genotype, in
order to improve the fit of the model to the data [45].
Multiplicative interactions were assessed by testing the significance
of an interaction term between two genotypes in the logistic
regression models by the Wald test. As many researchers believe
that departure from additivity is a better indicator of biologic
interaction than departure from multiplicativity [45,46], we also
calculated the attributable proportion (AP) of resistance due to
interactions between two genotypes. A positive AP is indicative of
synergy between the two genotypes, while a negative AP indicates
antagonism [47]. APs and corresponding 95% CIs for each of the
two-way interactions between genotypes were calculated based on
the output from the logistic regression models using the code
provided by Andersson et al [48] based on the methodology
described by Hosmer and Lemeshow [49]. All analyses were
performed with SAS version 9.1.
Results
Distribution of genotypes and resistance
The distribution of genotypes for each polymorphism and
frequency of resistance in each genotype are given in Table 1. A
higher percentage of car washers with a T allele (T/T or T/A) at
IFN-c +874 are resistant (T/A 65.2% and T/T 77.8%) than men
that are A/A homozygous (38.9%). For subsequent analyses, men
with T/A and T/T at the IFN-c +874 position were grouped as
the occurrence of resistance for each was significantly higher when
compared to homozygous individuals (A/A) and they did not differ
from each other. Among men heterozygous (C/T) at the IL-13
Cytokine Genes and Schistosomiasis
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41.9% of C/C and only 42.9% of T/T individuals were resistant
to reinfection (Table 1). Both homozygous genotypes for IL-13
21055 were grouped for the univariate analysis as the occurrences
of resistance in either of those genotypes were substantially lower
than in the heterozygous group and they did not differ from each
other. The frequency of homozygous C/C at IL-4 2590 was not
high enough in our cohort of men to allow analysis. However, men
heterozygous (C/T) at IL-4 2590 represent a higher percentage of
resistance (70.8%) than men that are T/T homozygous (40.9%).
No overt differences are seen in the proportions of the different
genotypes of IL-10 (21082; 2819; 2592) promoter SNPs in
relationship to resistance or susceptibility to reinfection, and as
expected due to linkage disequilibrium, SNPs at IL-10 2819 and
IL-10 2592 segregate together.
Polymorphisms in IL-13, IFN-c, IL-4, and IL-10 and
resistance
Resistance was significantly associated with the T allele at IFN-c
+874 (TT and TA) when compared to the homozygous A/A
individuals (OR 3.5 [CI 1.3, 9.4]) (Table 2). Car washers
heterozygous (C/T) at the IL-13 21055 position also showed a
significant correlation with resistance to reinfection when com-
pared to homozygous (C/C and T/T) car washers (OR 4.4 [CI
1.4, 13.4]) (Table 2), and heterozygousity (C/T) at the IL-4 2590
position correlated significantly with resistance when compared to
homozygous (T/T) car washers (OR 3.5 [CI 1.2, 10.2]) (Table 2).
These associations remained significant when all three genotypes
were included in a multivariate analysis, indicating an independent
association between resistance and each of the 3 genotypes
(Table 2). For IL-13 2591, there was no significant difference in
resistance between the A/A and A/G genotypes (Table 1,
p=0.2399). Having an A allele at the IL-13 +130 position was
associated with a modest increase in resistance relative to the
homozygous G/G genotype (OR=2.4 [0.9, 6.7]). However, when
IL-13 +130 and IL-13 21055 were evaluated simultaneously in a
logistic regression model, the association between resistance and
IL-13 +130 disappeared (OR=1.4 [0.4, 4.5]), while IL-13 21055
remained significantly associated with resistance. This suggests
that the observed relationship between resistance and IL-13 +130
was spurious and likely due to the close association between IL-13
+130 and IL-13 21055. Therefore, we only included the IL-13
21055 polymorphism in further analyses.
We found a relationship of borderline significance with IL-10
2819 or 2592 (any C versus homozygous G/G or A/A):
(OR=3.1 [0.9, 10.2], p=0.0577) and resistance to reinfection.
These two (2819 and 2592) polymorphisms are in tight linkage
disequilibrium; hence the results are interchangeable between the
two. The OR remained virtually unchanged in a model
controlling for the other three significant genotypes, indicating
that this possible low-grade association between resistance and the
IL-10 polymorphism was not confounded by its association with
another genotype. There were no significant additive or
multiplicative interactions between IL-10 2819 or 2592 and
any of the IL-4, IL-13 or IFN-c polymorphisms. No significant
associations were found with IL-10 21082 with resistance or
susceptibility (data not shown).
Associations between genotype and resistance within
categories of genotype interactions
Combination of the IL-13 21055 and IFN-c +874 genotypes
that were independently associated with resistance did not increase
the odds of being resistant over having either one of these
genotypes alone. However, although all combinations of IL-13 and
IFN-c genotypes had comparable odds of resistance when
compared to the reference group (Table 3), effect modification
was seen between the IL-13 and IFN-c genotypes. Among men
with a homozygous IL-13 genotype, having a T allele at the IFN-c
+874 position increased the odds of resistance relative to those
with the A/A genotype (OR=17.5 [CI 3.0, 101.5]) (Table 3).
There was no association between IFN-c genotype and resistance
among men with the heterozygous C/T IL-13 genotype. Likewise,
among men with homozygous A/A IFN-c genotype, the
heterozygous IL-13 genotype was associated with resistance
relative to the homozygous C/C or T/T genotypes (OR=22.5
[CI 3.5, 144.4]) (Table 3), while no association between IL-13 and
resistance was seen among men with a T allele in the IFN-c gene.
Men with a combination of the heterozygous C/T alleles for IL-
13 21055 and IL-4 2590 genes had more than a 20-fold
Table 1. IFN-c +874, IL-13 21055, IL-13 +130, IL-13 2591, IL-4
2590, IL-10 21082, IL-10 2819 and IL-10 2592 genotype
distributions and percentage of resistance.
Genotype Total N N (% susceptible) N (% resistant)
IFN-c +874
A/A 36 22 (61.1%) 14 (38.9%)
T/A 23 8 (34.8%) 15 (65.2%)
T/T 9 2 (22.2%) 7 (77.8%)
IL-13 21055
C/C 31 18 (58.1%) 13 (41.9%)
C/T 25 6 (24%) 19 (76%)
T/T 7 4 (57.1%) 3 (42.9%)
IL-13 +130
A/A 7 2 (28.6%) 5 (71.4%)
A/G 23 8 (34.8%) 15 (65.2%)
G/G 33 18 (54.5%) 15 (45.5%)
IL-13 2591
A/A 55 26 (47.3%) 29 (52.7%)
A/G 8 2 (25%) 6 (75.0%)
IL-4 2590
C/C 1 0 1 (100%)
C/T 24 7 (29.2%) 17 (70.8%)
T/T 44 26 (59.1%) 18 (40.9%)
IL-10 21082
A/A 38 21 (52.6%) 18 (47.4%)
A/G 27 12 (44.4%) 15 (55.6%)
G/G 4 1 (25%) 3 (75.0%)
IL-10 2819
C/C 14 5 (35.7%) 9 (64.3%)
C/T 39 17 (43.6%) 22 (56.4%)
T/T 16 11 (68.7%) 5 (31.3%)
IL-10 2592
C/C 14 5 (35.7%) 9 (64.3%)
C/A 39 17 (43.6%) 22 (56.4%)
A/A 16 11 (68.7%) 5 (31.3%)
doi:10.1371/journal.pntd.0000375.t001
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alleles at both genes (OR=20.1 [CI 2.3, 176.0]) (Table 3). Men
who were heterozygous for only one of the IL-13 or IL-4 genes
were not more likely to be resistant compared to men with both
homozygous alleles (Table 3). A significant additive interaction
between IL-13 and IL-4 genotypes was detected, with 90% of the
resistance among those with heterozygous alleles at both genes
attributable to the interaction between the two genes (AP=0.90
[0.64, 1.15]). In contrast, no significant additive or multiplicative
interactions were detected between IL-4 2590 and IFN-c +874
(Table 3).
Discussion
The car washers in this study are part of a longitudinal study that
dates back 12 years [40]. Their exposure (water contact) to infection
with S. mansoni is documented by the number of cars washed for
payment purposes, providing us with a unique, reliable means to
quantify an individual’s exposure in an active transmission site over
time. This longitudinal field setting allows us to account for water
contact as a variable and pose some interesting immunologic and
genetic questions with regard to what influences may play a role in
determining resistance to reinfection after treatment.
We found significant correlates between resistance to reinfection
with S. mansoni and the heterozygous (C/T) IL-13 21055
genotype, any T allele in the IFN-c +874 genotype, and the
heterozygous (C/T) in the IL-4 2590 genotype by univariate
analysis. Furthermore, these associations remained significant
when all three genotypes were included in a multivariate analysis,
indicating independent associations between resistance and each
of the 3 genotypes. However, our data suggest that having a
combination of the IL-13 C/T and an IFN-c T allele at +874 does
not provide increased odds of being resistant over having just one
of these genotypes. Instead, both IL-13 C/T and any IFN-c T
allele demonstrated very high odds of being resistant when
compared to the reference group. Our data did, however, show a
significant synergistic effect between the IL-13 21055 C/T and
IL-4 2590 C/T genotypes. Thus, the proportion of resistant men
seen with a combination of these two cytokine genotypes was
much greater than that seen with the sum of the separate effects of
IL-13 21055 C/T and IL-4 2590 C/T on resistance. We
interpret these data to indicate that individuals heterozygous at
the IL-13 21055 and IL-4 2590 position are more likely to
require fewer reinfections and treatments to become resistant to
reinfection than individuals who are homozygous at either
position.
Table 3. Odds ratios for the associations between genotype and resistance within categories of genotype interaction.
Interaction categories Odds Ratio (95% CI) Measures of interaction n (%) resistant
IL-13 and IFN-c
IL-13 CT, IFN-c TA/TT 26.3 (3.0, 226.6) AP
+=20.49 (23.09, 2.12) 7 (77.8)
IL-13 CT, IFN-c AA 22.5 (3.5, 144.4) Wald p-value
*=0.047 12 (75.0)
IL-13 CC/TT IFN-c TA/TT 17.5 (3.0, 101.5) 14 (70.0)
IL-13 CC/TT, IFN-c AA Ref 2 (11.8)
IL-13 and IL-4
IL-13 CT, IL-4 CT 20.1 (2.3, 176.0) AP
+=0.90 (0.64, 1.15) 13 (92.9)
IL-13 CT, IL-4 TT 1.9 (0.5, 7.6) Wald p-value
*=0.105 6 (54.5)
IL-13 CC, IL-4 CT 1.3 (0.3, 5.6) 4 (44.4)
IL-13 CC/TT, IL-4 TT Ref 11 (39.3)
IL-4 and IFN-c
IL-4 CT, IFN-c TA/TT 14.9 (2.2, 100.7) AP
+=0(21.75, 1.75) 7 (77.8)
IL-4 TT, IFN-c TA/TT 7.4 (1.9, 30.0) Wald p-value
*=0.240 14 (63.6)
IL-4 CT, IFN-c AA 8.5 (1.8, 39.2) 10 (66.7)
IL-4 TT, IFN-c AA Ref 4 (19.1)
+AP=attributable proportion.
*Wald test for interaction term in logistic regression model.
doi:10.1371/journal.pntd.0000375.t003
Table 2. Odds ratios for the associations between individual genotypes and resistance to reinfection by univariate and
multivariate analysis.
Genotype Univariate Multivariate*
OR (95% CI) p-value OR (95% CI) p-value
IL-13 21055 (C/T vs CC/TT) 4.4 (1.4, 13.4) 0.0086 6.3 (1.5, 26.0) 0.0109
IFN-c +874 (TT/TA vs A/A) 3.5 (1.2, 9.4) 0.0145 9.0 (2.0, 38.3) 0.0030
IL-4 2590 (C/T vs T/T) 3.5 (1.2, 10.2) 0.0192 4.3 (1.1, 17.4) 0.0419
*adjusted for the other 2 genotypes.
doi:10.1371/journal.pntd.0000375.t002
Cytokine Genes and Schistosomiasis
www.plosntds.org 5 February 2009 | Volume 3 | Issue 2 | e375Due to our small sample size, our interaction analysis resulted in
wide confidence intervals and we were unable to evaluate 3-way
interactions between groups. Also, because car washing is an
exclusively male profession at this study site, the associations in this
study apply to men and cannot necessarily be generalized to
women. However, these analyses provide interesting findings in a
situation that provides exceptional exposure data that are not
generally available in studies of resistance to reinfection. Clearly
our findings need to be investigated further in larger cohorts.
However, the current data provide initial insights into the potential
genetic foundation of propensities of people to develop resistance
to reinfection by schistosomes, and they offer a basis for further
molecular studies of how these polymorphisms might work at the
transcriptional and gene product level.
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